Vigabatrin Tablet
Product Images NDC 59651-367

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 59651-367). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Vigabatrin Fig1)

A cumulative percentage plot showing percent reduction from baseline in seizure frequency versus percentage of patients for Vigabatrin at doses of 1g/day, 3g/day, and 6g/day compared to placebo. The y-axis represents percent reduction in seizure frequency from -100% to 100%, indicating worsening to improvement, and the x-axis represents percent of patients from 100% to 0%. Different line styles distinguish placebo and the three Vigabatrin dose groups.*

FDA Label Image

Figure 2 (Vigabatrin Fig2)

A graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing the percentage reduction in seizure frequency versus percentage of patients. It compares two groups: one receiving placebo and the other Vigabatrin 3g/day, illustrating improvement and worsening in seizure frequency among patients.*

FDA Label Image

Package Label-principal Display Panel (500 mg (100 Tablets Bottle))

Label for Vigabatrin Tablets, USP 500 mg, oral tablet form, with a quantity of 100 tablets. The label includes storage instructions and distributor information for Aurobindo Pharma USA, Inc., made in India. It also features dosage information headings and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (500 mg (100 Tablets Carton Label))

Packaging label for Vigabatrin Tablets, USP 500 mg oral tablet from Aurobindo Pharma Limited. The label shows the NDC 59651-367-01, with a package size of 100 tablets. It instructs pharmacists to dispense the Medication Guide separately to each patient. Storage instructions and distributor information for Aurobindo Pharma USA, Inc. are also included.*

FDA Label Image

Str (Vigabatrin Str)

Chemical structure of Vigabatrin showing its molecular arrangement with an amino group, a vinyl side chain, and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.